08th week of 2014 patent applcation highlights part 42 |
Patent application number | Title | Published |
20140051721 | STABLE CRYSTALLINE SALT OF (R)-3-FLUOROPHENYL-3,4,5-TRIFLUOROBENZYLCARBAMIC ACID 1-AZABICYCLO [2.2.2]OCT-3-YL ESTER - The present invention refers to a stable crystalline salt of (R)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabicyclo [2.2.2]oct-3-yl ester and its use as medicament, in particular for the treatment of urinary incontinence or other diseases involving genitourinary disorders | 2014-02-20 |
20140051722 | TOPICAL LFA-1 ANTAGONISTS FOR USE IN LOCALIZED TREATMENT OF IMMUNE RELATED DISORDERS - This invention provides specifically formulated LFA-1 antagonists or pharmaceutically acceptable salts thereof that are suitable for topical delivery. In particular, the LFA-1 antagonists are particularly well suited for localized treatment by having a rapid systemic clearance rate. The invention also encompasses methods of treatment and prevention of immune related disorders using the LFA-1 topical formulations of the present invention. | 2014-02-20 |
20140051723 | DEUTERATED N-ETHYL-N-PHENYL-1,2-DIHYDRO-4-HYDROXY-5-CHLORO-1-METHYL-2-OXOQ- UINOLINE-3-CARBOXAMIDE, SALTS AND USES THEREOF - The subject invention provides deuterated N-ethyl-N-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, its salts and uses. | 2014-02-20 |
20140051724 | MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS - The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator, compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators. | 2014-02-20 |
20140051725 | Method For Increasing The Activity Of Lysosomal Enzymes - Method for enhancing in a mammalian cell the activity of an enzyme associated with Gaucher Disease by administering a competitive inhibitor of glucocerebrosidase in an amount effective to enhance the activity of the enzyme. Preferred compounds for use in the method are imino sugars and related compounds. In particular, C8-12-alkyl derivatives of N-alkyl-deoxynojirimycin, isofagomine compounds, and calystegine compounds are effective to enhance glucocerebrosidase activity. | 2014-02-20 |
20140051726 | 5-HT4 Receptor Agonist as a Prokinetic Agent - This invention relates to Compound A or a pharmaceutically acceptable salt thereof with 5-HT4 agonistic activities, which is useful in the treatment of gastrointestinal diseases. This invention also relates to a pharmaceutical composition for the treatment of gastrointestinal diseases which comprises a therapeutically effective amount of Compound A or a pharmaceutically acceptable salt thereof. Further this invention relates to a method for the treatment of gastrointestinal diseases in an animal subject including a mammalian subject, which comprises administering to the animal subject including a mammalian subject Compound A or a pharmaceutically acceptable salt thereof. | 2014-02-20 |
20140051727 | PYRIDONYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF - The invention provides pyridonyl guanidine compounds that inhibit F | 2014-02-20 |
20140051728 | DABIGATRAN IN TUMOR THERAPY - The invention relates to a new use of dabigatran etexilate of formula I | 2014-02-20 |
20140051729 | COMPOSITIONS AND METHODS FOR TREATING DEGENERATIVE MUSCLE CONDITIONS - Methods and compositions for treating degenerative muscle conditions are disclosed. The compositions disclosed herein include S1P promoting compositions that include an S1P promoting agent. Embodiments of the methods disclosed herein include administering therapeutically effective amounts to subjects suffering from a degenerative muscle condition, such as, for example, subjects suffering from sarcopenia and subjects suffering from muscular dystrophy, including subjects suffering from Duchenne Muscular Dystrophy and Becker Muscular Dystrophy. | 2014-02-20 |
20140051730 | THERAPEUTIC USE OF DIMIRACETAM TO PREVENT THE HAND AND FOOT SYNDROME CAUSED BY SORAFENIB - Dimiracetam is a suitable drug for treating and preventing allodynia, in particular allodynia of the hands and feet, that is or may be induced by antitumoral chemotherapeutic treatment with sorafenib. | 2014-02-20 |
20140051731 | METHOD FOR TREATMENT OF DISEASE CAUSED OR AGGRAVATED BY MICROORGANISMS OR RELIEVING SYMPTOMS THEREOF - A method for treating a disease or for treating a symptom of a disease, or a combination of both, the disease being caused or aggravated by microorganisms includes: treating the disease, treating the symptom of the disease, or reducing the duration of the disease, or a combination of both by administering a barrier-forming composition in a therapeutically effective amount to a surface, the surface comprising a mammal mucosa, the mammal being infected with the disease or experiencing symptoms of the disease caused or aggravated by the microorganisms. The barrier-forming composition includes an antimicrobial. Upon administering the composition, the method includes forming a barrier coating on the surface that is active to kill or neutralize microorganisms encountered by the barrier coating. A composition with an agent active for relieving symptoms of a disease is also included. | 2014-02-20 |
20140051732 | LOW-TACK SURFACE ANTI-MICROBIAL COATING COMPOSITION AND METHOD OF APPLICATION - A method for trapping and neutralizing or killing microorganisms on a surface includes: applying a low tack coating composition that comprises an antimicrobial agent onto an inanimate surface; in the coating, killing or neutralizing microorganisms encountered on the surface and encountered from the environment after the applying step is performed; forming a coating layer on the inanimate surface. The composition comprises a humectant and an antimicrobial, the antimicrobial including a monoquaternary ammonium compound or pharmaceutically acceptable salt thereof. The coating layer has antimicrobial cidal or static activity for at least about one hour. A low-tack antimicrobial composition is also included. | 2014-02-20 |
20140051733 | FEBUXOSTAT PHARMACEUTICAL COMPOSITIONS - The present application discloses stable pharmaceutical compositions for the oral administration of febuxostat with pharmaceutical excipients which provide improved dissolution rate and polymorphic stability both while manufacturing and during storage and process for preparing the stable compositions, packaging and their use in the treatment of gout of hyperuricemia. | 2014-02-20 |
20140051734 | Treatment of Type 2 Diabetes With a Combination of DPIV Inhibitor and Metformin or Thiazolidinedione - This invention relates to a therapeutic method for glycaemic control, in particular to a method for the treatment of Pi-type 2 diabetes, comprising the administration of a DPIV inhibitor together with metformin or a thiazolidinedione | 2014-02-20 |
20140051735 | USE OF N-PHENYLETHYLPYRAZOLE CARBOXAMIDE DERIVATIVES OR SALTS THEREOF FOR CONTROLLING POWDERY MILDEW PRIMARY INFECTIONS - The present invention relates to the use of N-phenylethylpyrazole carboxamide derivatives, in particular 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid [2-(2,4-dichlorophenyl)-2-methoxy-1-methyl-ethyl]-amide for controlling powdery mildew primary infections in crops and to a method for controlling those primary infections. | 2014-02-20 |
20140051736 | FUNGICIDAL COMPOSITIONS - The invention relates to fungicidal compositions comprising as active ingredient a combination of components A) and B) as defined in the patent claims, to a method of controlling phytopathogenic diseases on crop plants using such a composition and to a method of protecting natural substances of vegetable and/or animal origin and/or their processed forms using such a composition. | 2014-02-20 |
20140051737 | METHODS FOR THE TREATMENT AND DIAGNOSTIC OF PULMONARY ARTERIAL HYPERTENSION - The present application relates to the use at least one PARP inhibitor or a pharmaceutically acceptable salt thereof for the treatment of Group 1 pulmonary arterial hypertension (PAH) in a subject, including a human, in need of such treatment. There is also provided methods of treating and diagnosing Group 1 pulmonary arterial hypertension (PAH). | 2014-02-20 |
20140051738 | Oxymetazoline For The Treatment Of Ano-Rectal Disorders - Methods for treating fecal incontinence by administering to a subject in need thereof compositions including oxymetazoline as an active ingredient. Kits including compositions of oxymetazoline suitable for topical application, for the treatment of fecal incontinence. | 2014-02-20 |
20140051739 | PYRAZOLYL AND PYRIMIDINYL TRICYCLIC ENONES AS ANTIOXIDANT INFLAMMATION MODULATORS - Disclosed herein are novel antioxidant inflammation modulators, including those of the formula: | 2014-02-20 |
20140051740 | AMINOTETRAHYDROPYRANS AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES - The present invention is directed to novel substituted aminotetrahydropyrans of structural formula I which are inhibitors of the dipeptidyl peptidase-IV enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved. | 2014-02-20 |
20140051741 | CRYSTALLINE SALTS OF ASENAPINE - Disclosed is asenapine phosphate of formula (I) and its enantiomer (I) which can be used to prepare asenapine maleate. Further disclosed is a monoclinic crystalline form of asenapine maleate. | 2014-02-20 |
20140051742 | Lipophilic Curcumin Analogs And Methods Of Inhibiting HIV-1, Treating Latent HIV In The Brain, And Preventing HIV-Mediated Cognitive Decline And HIV Dementia - Compounds having formulas (I) to (VIII), salts thereof, or combinations thereof and pharmaceutical compositions comprising one or more these compounds are described herein for the treatment of HIV and neurodegenerative effects caused by HIV. Also provided herein are methods and a kit for inhibiting HIV-1, treating latent HIV in the brain, and preventing HIV-mediated cognitive decline and HIV dementia comprising administering the compounds having the formulas (I) to (VIII) and pharmaceutical compositions comprising the compounds having these formulas. The compounds having formulas I through VIII are curcumin analogs which are advantageously characterized as having anti-retroviral, neuroprotective, anti-glucosidase, and anti-HIV integrase properties. In one aspect, the pharmaceutical composition is delivered intranasally. | 2014-02-20 |
20140051743 | REGULATOR, PHARMACEUTICAL COMPOSITION ENCOMPASSING THE REGULATOR AND APPLICATION THEREOF - The present disclosure is directed to a regulator, a pharmaceutical composition encompassing the regulator and the application thereof The regulator modulates the expression integrins and/or EMP2, and is employed for treating integrins-associated and/or EMP2-associated diseases. | 2014-02-20 |
20140051744 | Markers For Assessing the Susceptibility of Cancer to Survivin-Targeting miRNA Treatment - The present invention relates to the use of miRNA treatment of survivin-positive cancer cells to increase sensitivity of cells to chemotherapy. | 2014-02-20 |
20140051745 | MICRO-RNAS OF THE MIR-15 FAMILY MODULATE CARDIOMYOCYTE SURVIVAL AND CARDIAC REPAIR - A family of microRNAs, called the miR-15 family, which includes miR-195, are shown to be up-regulated during pathological cardiac remodeling and repress the expression of mRNAs required for cell proliferation and survival, with consequent loss of cardiomyocytes. Strategies to block expression of the miR-15 family in the heart as a treatment for diverse cardiac disease are provided. | 2014-02-20 |
20140051746 | METHODS TARGETING MIR-128 FOR REGULATING CHOLESTEROL/LIPID METABOLISM - Methods for targeting microRNA 128 (miR-128) for regulating cholesterol/lipid metabolism and insulin sensitivity. | 2014-02-20 |
20140051747 | Compositions and Methods for Inhibiting Expression of an RNA from West Nile Virus - This invention relates to double-stranded ribonucleic acid (dsRNA), and its use in mediating RNA interference to inhibit the expression of an RNA from the West Nile virus (WNV), and the use of the dsRNA to treat pathological processes mediated by WNV infection, such as viral encephalitis. | 2014-02-20 |
20140051748 | OPTIMIZED miRNA CONSTRUCTS - The invention provides optimized miRNA sequences and their therapeutic use. The invention provides optimized miRNA constructs for treatment of neurodegenerative diseases. | 2014-02-20 |
20140051749 | SOLID FORMS OF AN ANTIVIRAL COMPOUND - Crystalline solid forms and the amorphous form of the anti-HCV compound 5-(3,3-dimethylbutyn-1-yl)-3-[(cis-4-hydroxy-4-{[(3S)-tetrahydrofuran-3-yloxy]methyl}cyclohexyl){[(1R)-4-methylcyclohex-3-en-1-yl]carbonyl}amino]thiophene-2-carboxylic acid (Compound I) were prepared and characterized in the solid state: | 2014-02-20 |
20140051750 | LOW-DOSE DOXEPIN FOR TREATMENT OF SLEEP DISORDERS IN ELDERLY PATIENTS - Methods of treating sleep disorders, particularly certain aspects of insomnia, in elderly patients (65 years and older) by administering initial daily dosages of doxepin of 1-3 mg. These ultra-low initial dosages are more effective in elderly versus non-elderly patients in decreasing wake time during sleep, latency to persistent sleep and wake time after sleep, and are particularly efficacious in treating those conditions in the last hour of an 8-hour sleep cycle. Also, the dosages described herein are safe for elderly individuals. | 2014-02-20 |
20140051751 | ENVIRONMENT-FRIENDLY ANTIFOULANTS FOR THE PREVENTION OF BIOFOULING - Environmentally-friendly alternatives to organometallic antifoulants that are efficacious at preventing biofouling by organisms such as the zebra mussel. Preferred antifoulant compositions utilize compounds having a Lipophilic-Amide-Spacer-ElectroNegative (“LASEN”) structural motif, such as capsaicin, and compounds having a TetraHydroCannibinoid (“THC”) structural motif. The antifoulant compositions are non-toxic, and effective. | 2014-02-20 |
20140051752 | Treatment of Obesity Using Non-Daily Administration of 6-O-(4-Dimethylaminoethoxy) Cinnamoyl Fumagillol - The invention generally relates to methods of treating an overweight or obese subject, and treating overweight- or obesity-related conditions using non-daily administration of e.g, a MetAP-2 inhibitor. | 2014-02-20 |
20140051753 | PHENYLCARBAMATE COMPOUND AND MUSCLE RELAXANT CONTAINING THE SAME - A novel phenylcarbamate compound and a pharmaceutical composition containing the same are provided. More specifically, a novel phenylcarbamate compound, a composition for muscle relaxation containing the phenylcarbamate compound as an active ingredient, and a method of muscle relaxation comprising administering a therapeutically effective amount of the phenylcarbamate compound, are provided. | 2014-02-20 |
20140051755 | Continuous Administration of L-Dopa, Dopa Decarboxylase Inhibitors, Catechol-O-Methyl Transferase Inhibitors and Compositions for Same - Provided herein, in part, is a method of treating a neurological or movement disorder in a patient in need thereof, comprising subcutaneously administering to said patient a pharmaceutically acceptable composition comprising levodopa and optionally carbidopa and optionally entacapone or tolcapone, or pharmaceutically acceptable salts thereof, wherein said composition is administered substantially continuously, and compositions that can be used in the disclosed methods. | 2014-02-20 |
20140051756 | METHOD FOR PREVENTING OR TREATING ARRHYTHMIA, METHOD FOR PREVENTING OR TREATING ATRIAL FIBRILLATION, MODEL OF SUSTAINED ATRIAL FIBRILLATION, METHOD FOR PRODUCING THE MODEL, AND METHOD FOR SCREENING FOR ATRIAL FIBRILLATION INHIBITOR - A method for preventing or treating atrial fibrillation, including:
| 2014-02-20 |
20140051757 | THERAPEUTICAL METHOD FOR THE TREATMENT OF THE LEBER OPTIC NEUROPATHY - It is described the use of L-carnitine and/or one or more alkanoyl L-carnitines, or mixture thereof, or one of their pharmaceutically acceptable salts, for the preparation of a medicament or a nutritional supplement useful for preventing or treating the Leber optic neuropathy. | 2014-02-20 |
20140051758 | HIGH PURITY 2-[4-(3- OR 2-FLUOROBENZYLOXY)BENZYLAMINO] PROPANAMIDES AND METHODS OF USE THEREOF - A process for obtaining therapeutically active 2-[4-(3- and 2-(fluorobenzyloxy)benzylamino]propanamides, and their salts with pharmaceutically acceptable acids with high purity degree, in particular, with a content of dibenzyl derivatives impurities lower than 0.03%, preferably lower than 0.01% by weight. The process is carried out by submitting the Schiff bases intermediates 2-[4-(3- and 2-fluorobenzyloxy)benzylideneamino]propanamides to a reduction reaction with a reducing agent selected from sodium borohydride and potassium borohydride in an appropriate amount of an organic solvent selected from C | 2014-02-20 |
20140051759 | BIPOLAR TRANS CAROTENOID SALTS AND THEIR USES - The invention relates to trans carotenoid salt compounds, methods for making them, methods for solubilizing them and uses thereof. These compounds are useful in improving diffusivity of oxygen between red blood cells and body tissues in mammals including humans. | 2014-02-20 |
20140051760 | Hybrid Molecule Having Mixed Retinoic Acid Receptor Agonism and Histone Deacetylase Inhibitory Properties - Hybrid molecules comprising a retinoic acid receptor agonist moiety and a histone deacetylase inhibitor (HDAC) moiety are disclosed. Hybrid molecule 3 (6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)naphthalene-2-hydroxamic acid) was proven to posses HDAC activity while maintaining RAR agonist activity. Hybrid molecule 3 and pharmaceutical compositions thereof can be used in the treatment of breast cancer, leukemia, non-small cell lung cancer, colon cancer, melanoma, ovarian cancer, renal cancer, prostate cancer and cancer of the CNS. | 2014-02-20 |
20140051761 | KATP ANTAGONISTS (GLIBENGLAMID) FOR USE FOR PROMOTING GROWTH AND/OR TREATING HYPERGLYCAEMIA OF A PREMATURE INFANT - The present invention relates to pharmaceutical compositions comprising an ATP-sensitive potassium (K ATP) channel antagonist (e.g., sulfonylureas, meglitinides) and methods for treating hyperglycaemia and/or promoting growth of a premature and/or small for gestational age infant. | 2014-02-20 |
20140051762 | POLYCATIONIC COMPOUNDS AND USES THEREOF - Aspects of the present invention relate to compounds and methods useful in modulating angiogenesis and methods of treating or preventing diseases associated with angiogenesis by administering a polycationic compound. The present invention relates to methods of use and compositions for inhibiting angiogenesis-mediated disorders in mammals including animals and humans. Additionally, this invention relates to the combined use of polycations with other anti-angiogenesis agents for the treatment of different angiogenesis-mediated disorders. Additionally, those polycationic compounds can be used with various anti-inflammatory and cytotoxic agents as well as with radio-therapeutic agents in cancer patients to prevent and treat tumor growth and metastasis. | 2014-02-20 |
20140051763 | METHODS OF TREATING FRONTAL TEMPORAL DEMENTIA (FTD) WITH COMPRISING ADMINISTERING METAL CHELATORS TO THE UPPER ONE-THIRD OF THE NASAL CAVITY - The present invention comprises methods and pharmaceutical compositions for intranasal delivery of effective amounts of DFO directly to the CNS, in particular the brain treatments that inhibit GSK3b in patients with psychiatric disorders including, but not limited to, bipolar disorder, depression, ADHD and schizophrenia. In addition a treatment composition is disclosed which comprises DFO and in certain embodiments combines DFO with one or more of the psychotropic drug types, i.e., antipsychotics, mood stabilizers and antidepressants. Moreover, a treatment for treating impairment of neural plasticity through inhibition of GSK3b is provided as well as prevention of apoptosis of cells through inhibition of GSK3b. | 2014-02-20 |
20140051764 | SOLID FORMS OF SELECTIVE ANDROGEN RECEPTOR MODULATORS - The present invention relates to solid forms of (S)—N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide and process for producing the same. | 2014-02-20 |
20140051765 | PHARMACEUTICAL FOR ORAL DELIVERY COMPRISING MGBG AND METHODS OF TREATING DISEASE - Disclosed herein are new oral pharmaceutical compositions of MGBG and related polyamine analogs, polyamine biosynthesis inhibitors, polyamine inhibitors of AMD-I and regulators of osteopontin, and their application for the treatment of disease. | 2014-02-20 |
20140051766 | Organic Compounds - The present invention relates to crystalline forms and hydrates of 2-Amino-2-[2-(4-C | 2014-02-20 |
20140051767 | PARENTERAL FORMULATIONS OF RASAGILINE - This application provides a method of preferentially inhibiting monoamine oxidase A (MAOA) in the brain of a subject relative to in the intestine of the subject comprising parenterally administering to the subject a controlled release formulation comprising a therapeutically effective amount of rasagiline or a pharmaceutically acceptable salt thereof. | 2014-02-20 |
20140051768 | METHOD OF TREATING DISEASES THAT RESPOND TO THERAPY BY DOPAMINE OR DOPAMINE AGONISTS - The invention relates to a medicament containing (S)-2-N-propylamino-5-hydroxytetralin, the salts or prodrugs thereof. As a D3 agonist, (S)-2-N-propylamino-5-hydroxytetralin is suitable particularly for the treatment of dopa-sensitive movement disorders. | 2014-02-20 |
20140051769 | METHOD AND COMPOSITION FOR IMPROVING THE HEALTH OF YOUNG MONOGASTRIC MAMMALS - A method of improving the health of a first group of young monogastric mammals, the first group of young monogastric mammals nursing from a first lactating monogastric mammal during a pre-weaning period, the method including feeding the first lactating monogastric mammal an effective amount of an animal feed during the pre-weaning period, and feeding the first lactating monogastric mammal an effective amount of sugar alcohol during the pre-weaning period. | 2014-02-20 |
20140051770 | INJECTABLE MULTIMODAL POLYMER DEPOT COMPOSITIONS AND USES THEREOF - Injectable depot compositions are provided that include a polymer matrix having a plurality of bioerodible, biocompatible polymers wherein each polymer of the plurality of polymers has a specified weight average molecular weight; and the polymer matrix has a broad molecular weight distribution of the plurality of polymers; a solvent having a miscibility in water of less than or equal to 7 wt. % at 25° C., in an amount effective to plasticize the polymer and form a gel therewith; and a beneficial agent. The compositions are have substantially improved the shear thinning behavior and reduced injection force, rendering the compositions readily implanted beneath a patient's body surface by injection. | 2014-02-20 |
20140051771 | Biomedical Devices Comprising Molded Polyethylene Components - A molded polyethylene component that comprises polyethylene having a melt flow index of about 3.5 g/10 min or greater as measured by ASTM D1238 at 190° C./21.5 kg weight and having an ash content of about 500 ppm or less may be useful biomedical devices, including kits and methods relating thereto. | 2014-02-20 |
20140051772 | CLEANING AGENT COMPOSITION - The problem of the present invention is provision of a cleansing composition providing good amount and good quality of lather. Using a particular alkenoic acid or a salt thereof, the above-mentioned problem can be solved. In addition, the cleansing composition provided by the present invention is stable in various formulations and also useful for rough skin and damaged hair. | 2014-02-20 |
20140051773 | METHODS FOR PREDICTING RISK OF DEVELOPING HYPERTENSION - Methods using biomarkers, e.g., serum levels of ST2, to predict risk of developing hypertension, as well as methods for treating subjects to reduce the risk of developing hypertension and methods for selecting and/or stratifying subjects for clinical trials of treatments to reduce the risk of hypertension. | 2014-02-20 |
20140051774 | METHOD AND DEVICE FOR PRODUCING COMPOSITION HAVING DISPERSED PHASE FINELY DISPERSED IN CONTINUOUS PHASE - An object of the present invention is to provide a method for producing a composition having a disperse phase finely dispersed in a continuous phase with low polydispersity, the method which is excellent in production efficiency | 2014-02-20 |
20140051775 | METHOD AND APPARATUS FOR PRODUCING LIQUID HYDROCARBON FUELS - A method of converting coal into a liquid hydrocarbon fuel utilizes a high pressure, high temperature reactor which operates upon a blend of micronized coal, a catalyst, and steam. Microwave power is directed into the reactor. The catalyst, preferably magnetite, will act as a heating media for the microwave power and the temperature of the reactor will rise to a level to efficiently convert the coal and steam into hydrogen and carbon monoxide. | 2014-02-20 |
20140051776 | IMPROVED STABILITY OF POLYURETHANE POLYOL BLENDS CONTAINING HALOGENATED OLEFIN BLOWING AGENTS - A polyol pre-mix composition includes a blowing agent having a halogenated hydroolefin, a polyol, a surfactant, a catalyst composition, and a metal salt. The metal salt may be, for example, a carboxylate, acetylacetonate, alcoholate of a metal selected from the group consisting of Zn, Co, Ca, and Mg. The metal salt may be, for example, a carboxylate and/or alcoholate of a C1-C21 straight chain or branched aliphatic monocarboxylic acid or monoalcohol, such as magnesium formate, zinc octoate, calcium octoate, cobalt octoate, and magnesium octoate, and mixtures thereof. The metal acetylacetonate may be, for example, zinc acetylacetonate, cobalt acetylacetonate, magnesium acetylacetonate, or calcium acetylacetonate. A two-part system for producing a thermosetting foam blend includes (a) a polyisocyanate and, optionally, one or more isocyanate compatible raw materials; and (b) the polyol pre-mix composition. A method for producing a thermosetting foam blend includes combining: (a) a polyisocyanate; and (b) the polyol pre-mix composition. | 2014-02-20 |
20140051777 | FOAM MATERIAL PRODUCT - A method of producing a foam product subjects a body of expanded closed-cell foam, in particular expanded polystyrene particle foam, to a non-melting heat treatment at a temperature above the glass transition temperature of the plastic used to form the foam, in particular polystyrene. The volume of the foam product is reduced by the heat treatment compared with the initial state prior to the heat treatment by a value from a range between a lower limit of 50% and an upper limit of 97%. | 2014-02-20 |
20140051778 | FINE PARTICLE, HIGH CONCENTRATION, POLYISOCYANATE POLYADDITION/POLYURETHANE-UREA POLYOLS - Embodiments of the invention include a method of producing polymer polyol dispersions is. The method includes providing at least one reaction system, and the reaction system includes: a) at least one polyol, b) at least one seed population, c) at least one catalyst, d) at least one co-reactant having an equivalent weight of up to 400 and at least one active hydrogen attached to a nitrogen or oxygen atom, and e) at least one polyisocyanate. The at least one seed population includes less than about 5% by weight of the total weight of the at least one reaction system and includes seed particles having diameters of less than 5 μm. The at least one reaction mixture reacts to form at least one of a polyurea and polyurethane-urea particle population in the at least one polyol without the addition of any catalysts comprising tin. The polymer polyol dispersion has a solids content of at least 15% of the weight of the polymer polyol dispersion. | 2014-02-20 |
20140051779 | SEEDING PROCESS FOR THE MANUFACTURE OF POLYMER MODIFIED POLYOLS - Embodiments of the invention provide for polymer polyols and methods of producing polymer polyols. Methods include providing at least one first composition which includes at least one polyol, at least one isocyanate non-reactive seed population, and at least one of a co-reactant having an equivalent weight of up to 400 and at least one active hydrogen attached to a nitrogen or oxygen atom. The at least one isocyanate non-reactive seed population includes less than about 5% by weight of the total weight of the first composition, and the seed population has a maximum particle diameter of less than 10 The first composition is combined with at least one polyisocyanate under mixing to form at least one of a polyurea, polyurethane, and a polyurethane-urea particle population dispersed in the first composition, wherein at least 90% by weight of the particle population has a particle diameter of less than 100 μm. | 2014-02-20 |
20140051780 | COPOLYESTERS HAVING REPEAT UNITS DERIVED FROM w-HYDROXY FATTY ACIDS - The present invention relates to aliphatic or aliphatic-aromatic polyesters and copolyesters comprised of biobased ω-hydroxyfatty acids or derivatives thereof, processes for the preparation thereof, and compositions thereof having improved properties. The copolyesters of the present invention may also contain additional components that can be selected from aliphatic or aromatic diacids, diols and hydroxyacids obtained from synthetic and natural sources. The biobased ω-hydroxyfatty acids that comprise the polyesters and copolyesters of the present invention are made using a fermentation process from pure fatty acids, fatty acid mixtures, pure fatty acid ester, mixtures of fatty acid esters, and triglycerides from various sources. The polyesters of the present invention may contain various amounts and types of ω-carboxyfatty acids depending on the engineered yeast strain used for the bioconversion as well as the feedstock(s) used. | 2014-02-20 |
20140051781 | COMPOSITE FOR BLACK MATRIX RESIST, METHOD FOR MANUFACTURING BLACK MATRIX RESIST, COLOR FILTER ARRAY PANEL, AND METHOD FOR MANUFACTURING THE SAME - A resist composition for a black matrix, the resist composition including carbon nanotubes, a halosulfonic acid, an alcohol, an ammonium hydroxide compound, and a fluorosilane. | 2014-02-20 |
20140051782 | PROCESS FOR PRODUCING A DENTAL FILLER - A process for producing a particulate dental filler in which a dental particulate inorganic material is admixed with a curable organic monomeric material containing acrylate groups to produce a suspension in a liquid. The suspension is spray dried to produce an atomized powder and the monomeric material is cured. | 2014-02-20 |
20140051783 | ECO-FRIENDLY RESIN COMPOSITION - Disclosed is an eco-friendly resin composition. The eco-friendly resin composition includes a base resin of about 100 parts by weight and a polyvinylacetal compatibilizer of about 1 to about 20 parts by weight. The base resin includes a plasticized cellulose diacetate of about 10 wt % to about 50 wt % and a thermoplastic resin of about 50 wt % to about 90 wt %. | 2014-02-20 |
20140051784 | EPOXY SYSTEMS AND AMINE POLYMER SYSTEMS AND METHODS FOR MAKING THE SAME - Compositions and methods for forming surfactants, aqueous dispersions, and curing agents are provided. In one aspect, the invention relates to improved epoxy functional surfactants prepared by reaction of an epoxy composition and an amidoamine composition formed from a blend of acid-terminated polyoxyalkylene polyols. The improved epoxy functional surfactants may be reacted with an excess of epoxy composition and water to result in an aqueous dispersion. The amidoamine composition may be a reaction mixture of a diamine compound and an acid terminated polyoxyalkylene composition formed from two or more polyoxyalkylene polyol compounds. The epoxy functional surfactant may be reacted with amine compounds to form a compound suitable as a curing agent. | 2014-02-20 |
20140051785 | HIGH DENSITY MEMBRANE PROTEIN MEMBRANES - Embodiments of the invention provide methods for preparing high density membrane protein membranes by slow, controlled removal of detergent from mixtures of detergent, block copolymers and membrane protein mixtures. Membranes created by this method are also provided. The structure of these membranes may be varied by varying the amount of membrane protein. | 2014-02-20 |
20140051786 | LONG-FIBER-REINFORCED FLAME-RETARDANT POLYESTERS - Thermoplastic molding compositions comprising
| 2014-02-20 |
20140051787 | BIOBASED MODIFIERS FOR POLYVINYLCHLORIDE BLENDS - Compositions of polymer blends of polyvinylchloride (PVC) and polyhydroxyalkanoate (PHA) are described. In certain embodiments, the PHA is a poly-3-hydroxybutyrate-co-4-hydroxybutyrate copolymer having a weight percent 4-hydroxybutyrate of 30-45%. In other embodiments the PHA is a multiphase P3HB-4HB copolymer blend having one phase fully amorphous. The PHA is mixed with the PVC to optimize its optical, thermal and mechanical properties. In certain embodiments, the polymer is branched with optionally additives that improve properties. Methods of making the compositions of the invention are also described. The invention also includes articles, films and laminates comprising the compositions. | 2014-02-20 |
20140051788 | INSULATING SILICONE RUBBER COMPOSITION - An insulating silicone rubber composition superior in reliability is provided that has excellent antistatic property while being free from bleeding, blooming, and discoloration. The insulating silicone rubber contains silicone rubber, ionic liquid having an alkoxysilyl group, and preferably a crosslinking agent. The content of the ionic liquid is preferably within a range from 0.001 to 5 parts by mass with respect to 100 parts by mass of the total amount of the silicone rubber and the crosslinking agent. | 2014-02-20 |
20140051789 | ADHESION PROMOTING ADDUCTS CONTAINING METAL LIGANDS, COMPOSITIONS THEREOF, AND USES THEREOF - Disclosed are adhesion promoting adducts containing adhesion promoting groups and metal ligands and compositions such as sealant compositions useful in aerospace applications comprising the adhesion promoting adducts. The adhesion promoting adducts are useful as adhesion promoting additives or as a copolymerizable reactant in polymer compositions. | 2014-02-20 |
20140051790 | VINYLIDENE FLUORIDE-BASED RESIN FILM, SOLAR CELL BACK SHEET, AND SOLAR CELL MODULE - Provided is a vinylidene fluoride-based resin film resistant to pinhole generation caused by dispersion insufficiency and superior in thermal stability during molding processing, even if it contains a pigment in a large amount, and a solar cell back sheet and a solar cell module comprising the same. | 2014-02-20 |
20140051791 | RUBBER COMPOSITION - The present invention provides a rubber composition containing: (A) a rubber component containing 10% by mass or more of at least one kind of rubber selected from diene rubber synthesized by emulsion polymerization and natural rubber and 90% by mass or less of another kind of diene rubber; (B) silica having a n-hexadecyltrimethylammonium bromide (CTAB) adsorption specific surface area of not less than 180 m | 2014-02-20 |
20140051792 | RUBBER COMPOSITION - The present invention provides a rubber composition containing: (A) a rubber component containing from 90 to 100% by mass of at least one kind of diene rubber synthesized by solution polymerization and from 0 to 10% by mass of another kind of diene rubber; (B) a silica having a n-hexadecyltrimethylammonium bromide (CTAB) adsorption specific surface area of 180 m | 2014-02-20 |
20140051793 | RUBBER COMPOSITION - The present invention provides a rubber composition containing: (A) a rubber component containing 10% by mass or more of at least one kind of rubber selected from diene rubber synthesized by emulsion polymerization and natural rubber and 90% by mass or less of another kind of diene rubber; (B) silica having a n-hexadecyltrimethylammonium bromide (CTAB) adsorption specific surface area of less than 140 m | 2014-02-20 |
20140051794 | Thermoplastic Poly(Arylene Ether)/Polyamide Blends and Method of Making - A thermoplastic composition comprises:
| 2014-02-20 |
20140051795 | HIGH IMPACT LONG FIBER REINFORCED POLYAMIDE COMPOSITION - Disclosed herein are composition and methods. The compositions are fiber reinforced thermoplastic composition comprising an impact strength increasing additive and/or a mechanical property improving additive. | 2014-02-20 |
20140051796 | PHOSPHORUS-CONTAINING COMPOUNDS USEFUL FOR MAKING HALOGEN-FREE, IGNITION-RESISTANT POLYMERS - Phosphorus-containing compounds useful for flame retardant epoxy resins are disclosed. The flame retardant epoxy resins may be used to make electrical laminates. This invention is particularly useful in end use applications in which a low bromine or low halogen content is required or desired. | 2014-02-20 |
20140051797 | WATER/OIL REPELLENT COMPOSITION, METHOD FOR ITS PRODUCTION AND ARTICLE - To provide a water/oil repellent composition which can impart sufficient post-air-drying water/oil repellency to the surface of an article, and which presents a low environmental impact, and an article having its surface treated with the water/oil repellent composition. A water/oil repellent composition comprising a copolymer (A) having structural units based on a monomer (a), structural units based on a monomer (b), structural units based on a monomer (c) and/or structural units based on a monomer (d); and an aqueous medium (B) containing water, and a film-forming assistant (x) and/or a film-forming assistant (y). Monomer (a): a monomer having a C | 2014-02-20 |
20140051798 | CATIONIC WATER BASED POLYMERS FOR INKJET INKS - The present invention provides a durable, external surfactant free, cationic, water based jet ink polymer which when formulated into an ink jet ink results in a printing that has an excellent adhesion to metal or plastic substrates. Such a jet ink polymer is suitable performance replacement of solvent soluble polymers currently in commercial use. The hybridized copolymer comprises a hydrophobic functional polymeric backbone comprised of a polysiloxane polymer, a polyolefin polymer, or a functional polyvinyl polymer. The hybridized copolymer also comprises a plurality of copolymeric side chains attached to the backbone, comprising a polymerizable amine-containing unsaturated monomer, and a polymerizable unsaturated monomer. The use of the inks of the present invention enhances performance criteria such as print-head open time, ink stability, and resistance to typical water based cleaners. | 2014-02-20 |
20140051799 | MODIFIED CONJUGATED DIENE RUBBER, METHOD FOR PRODUCING SAME, AND RUBBER COMPOSITION - A method containing a step of reacting a conjugated diene polymer having an alkali metal or alkaline earth metal active end with a hydrocarbyloxysilane compound having one or more of each of the following functional groups I and II in its molecule to obtain a modified conjugated diene polymer containing a functional group II, and a step of mixing the modified conjugated diene polymer and a compound such as organic acid. A modified conjugated diene rubber which can be used as a raw material of a cross-linked rubber which can be used in tire treads and the like and can enhance low fuel consumption performance is provided. The functional group I is a hydrocarbyloxysilyl group. The functional group II is a nitrogen-containing group in which both of two hydrogen atoms of a primary amino group are substituted with protective groups. | 2014-02-20 |
20140051800 | WATER-EMULSIFIABLE POLYISOCYANATE COMPOSITION COMPRISING A FRAGRANT WITH AT LEAST ONE HYDROXYL AND/OR ALDEHYDE GROUP - An aqueous composition comprises a water-emulsifiable polyisocyanate (A), the water-emulsifiable polyisocyanate (A) being a reaction product of a polyisocyanate (B) with a compound (C) which contains at least one sulfonic acid group or its anion, and at least one isocyanate-reactive group. The composition further comprises a fragrant (D1) with at least one hydroxyl and/or aldehyde group. It has been found that the addition of the fragrant (D1) can mask unpleasant odors of the composition. This is particularly the case when organic co-solvents such as propylene glycol-n-butyl ether and/or 3-methoxy-1-butyl acetate are used. The storage stability and performance of the polyisocyanates are not affected by the addition of the fragrant (D1). Further aspects of the invention are the use of a composition according to the invention as an adhesive, a coating or an impregnating material and a substrate coated with a composition according to the invention. | 2014-02-20 |
20140051801 | POLYMER OF MALEIC ACID, ALLYL ETHER AND (METH)ACRYLIC ACID COMPOUNDS, AND PREPARATION AND USE THEREOF - The invention relates to comb polymers of maleic acid or derivatives thereof, allyl ethers and (meth)acrylic acid or derivatives thereof, and to the preparation thereof by free radical polymerization at a reaction temperature of 10° C. to 50° C. The invention further relates to the use of such comb polymers for improving the processability of hydraulically setting compositions. | 2014-02-20 |
20140051802 | HIGH PURITY BISPHENOL-A AND POLYCARBONATE MATERIALS PREPARED THEREFROM - Methods for performing a condensation reaction are disclosed. Specifically, various methods for the production of highly-pure bisphenol-A are disclosed in which an attached promoter ion exchange resin catalyst system is combined with a solvent crystallization step. | 2014-02-20 |
20140051803 | HIGH PURITY BISPHENOL-A AND POLYCARBONATE MATERIALS PREPARED THEREFROM - A modified ion exchange resin catalyst having an attached dimethyl thiazolidine promoter is disclosed. Also disclosed is a process for catalyzing condensation reactions between phenols and ketones, wherein reactants are contacted with a modified ion exchange resin catalyst having an attached dimethyl thiazolidine promoter. Also disclosed is a process for catalyzing condensation reactions between phenols and ketones that does not utilize a bulk promoter. | 2014-02-20 |
20140051804 | POLYSILANESILOXANE RESINS FOR USE IN AN ANTIREFLECTIVE COATING - Polysilanesiloxane copolymers or resins and method of making are provided. The present disclosure further provides a method of applying the polysilanesiloxane copolymers onto a substrate to form a polysilanesiloxane film for use in photolithography (193 nm). The polysilanesiloxane films meet the basic performance criteria expected or desired for use in an antireflection coating (ARC) application, | 2014-02-20 |
20140051805 | WATER/OIL REPELLENT COMPOSITION, METHOD FOR ITS PRODUCTION AND ARTICLE - To provide a water/oil repellent composition with which an article which has favorable water/oil repellency and washing durability, and into which infiltration of a coating liquid can be suppressed, is obtained, and which presents a low environmental impact, its production method and an article having its surface treated with the composition. A water/oil repellent composition comprising a copolymer (X) having structural units based on the monomer (a) and structural units based on the monomer (b), and an aqueous medium, wherein the mass average molecular weight of the copolymer is at least 60,000, and the proportion of the structural units based on the monomer (a) is 60 to 95 mass %. Monomer (a): by (Z—Y) | 2014-02-20 |
20140051806 | ADDITION CURABLE SELF-ADHESIVE SILICONE RUBBER COMPOSITION - An addition curable self-adhesive silicone rubber composition comprising (A) an organopolysiloxane containing alkenyl at either end, (B) an organosilicon compound containing phenylene and SiH group, (C) an organohydrogenpolysiloxane containing two SiH groups, (D) an organohydrogenpolysiloxane containing at least three SiH groups, and (E) an addition reaction catalyst is integrally moldable with thermoplastic resins. | 2014-02-20 |
20140051807 | Polymers Derived from Rosin and Their Methods of Preparation - Methods of forming polymer material from rosin-derived material are provided, along with the resulting polymers. For example, a plurality of functionalized resin acids having a polymerizable functional group via controlled living polymerization can be polymerized into the polymeric material such that each polymer defines a functional end group and the polymeric material has a polydispersity index of about 1 to about 1.5. | 2014-02-20 |
20140051808 | Highly Branched Compositions and Processes for the Production Thereof - A highly branched polyolefin having olefin derived units; wherein the highly branched polyolefin has: (i) a branching index, g′(vis), of less than about 0.9; (ii) a phase angle, δ, of less than about 55 degrees at a complex modulus of 10 kPa, measured at 190° C.; (iii) a gel content of less than or equal to about 10%; and (iv) a melting point of less than about 135° C.; wherein the highly branched polyolefin is obtained by contacting one or more polyolefins with a free radical generator. The highly branched polyolefin may also comprise a modifying polymer, wherein the modifying polymer may be the similar or dissimilar to the polyolefin. Methods of producing these highly branched polyolefins and blends of these highly branched polyolefins are also disclosed. | 2014-02-20 |
20140051809 | Long Chain Branched EPDM Compositions and Processes for Production Thereof - Highly branched compositions including: (i) from about 96 wt % to about 99.9 wt % metallocene catalyzed ethylene propylene diene derived units; and (ii) from about 0.1 wt % to about 4 wt % multifunctional monomer derived units, wherein the highly branched composition has: (a) a Mooney viscosity ML (1+4) at 125° C. of about 30 to 100 MU, (b) a Mooney relaxation area MLRA of about 100 to about 1000, (c) a branching index, g′(vis) of less than about 0.9, (d) a phase angle, δ, of less than about 55 degrees at a complex modulus of 10 kPa, measured at 190° C., and (e) a degree of shear thinning greater than about 0.95, measured at 190° C., are disclosed herein. Homogeneous blends including this composition are also described. Processes to make the highly branched composition and the homogeneous blend are also described herein. | 2014-02-20 |
20140051810 | PHOSPHONIUM IONOMERS COMPRISING PENDANT VINYL GROUPS AND PROCESSES FOR PREPARING SAME - The present invention relates to ionomers comprising a reaction product of the reaction between a halogenated isoolefin copolymer and at least one phosphorus based nucleophile comprising at least one pendant vinyl group. The present invention also relates to a method of preparing and curing these ionomers. | 2014-02-20 |
20140051811 | RESIN MATERIAL - A resin material contains a polymer of a composition containing an isocyanate and an acrylic resin having OH-group-containing side chains in which a proportion of OH-group-containing side chains each having 6 or more carbon atoms relative to all of the OH-group-containing side chains is about 76 mol % or more and about 100 mol % or less. | 2014-02-20 |
20140051812 | POLYMERIC SURFACE OXIDATION USING PERACIDS - A method for oxidizing polymeric surfaces to render them hydrophilic and more amenable to wetting is disclosed. The method comprises reacting the surface of a hydrophobic polymer with a peracid, especially Caro's acid, under conditions effective to render the surface more hydrophilic. Although strong oxidants can easily carbonize or discolor the surface of organic polymers, polymers can be rendered more hydrophilic without these problems when process conditions are carefully controlled. Specifically, treatment of the polymer surface with a peracid such as Caro's acid requires judicious selection of oxidation temperature, acid concentration, and peroxide content to achieve reaction rates that provide the desired level of hydrophilicity without charring or otherwise damaging the polymer. | 2014-02-20 |
20140051813 | PREPARATION METHOD OF SUPERABSORBENT POLYMER - The present invention relates to a preparation method of a superabsorbent polymer, and specifically to a method of preparing a superabsorbent polymer including the steps of: preparing a hydrous gel phase polymer by thermal polymerizing or photo-polymerizing a monomer composition including a water-soluble ethylene-based unsaturated monomer and a polymerization initiator; drying the hydrous gel phase polymer; milling the dried polymer; classifying the milled hydrous gel phase polymer into two or more grades by particle size; adding a surface cross-linking agent to each hydrous gel phase polymer classified into two or more grades; and carrying out a surface cross-linking reaction of the hydrous gel phase polymer to which the surface cross-linking agent is added. | 2014-02-20 |
20140051814 | Photosensitive Alkali-Soluble Resin, Method Of Preparing The Same, And Color Photosensitive Resist Containing The Same - Provided is a photosensitive alkali-soluble resin comprising a compound of formula (I), a method of preparing the same, and a color photosensitive resist containing the same, wherein n1, n2, R | 2014-02-20 |
20140051815 | ORGANIC SULFONIC ACID COMPOUND, DOPANT HAVING SAME, AND CONDUCTIVE POLYMER COMPLEX HAVING THE DOPANT - The present disclosure relates to an organic sulfonic acid-based compound and a preparation method thereof, a dopant including the compound, and a conductive polymer composite including the dopant, and more specifically, provides a dopant including a derivative compound containing a sulfonic acid group connected to a benzene ring via a flexible chain to enhance the solubility and the dispersibility in a general solvent, and the environment-resistance thereof, thus increasing the electric conductivity and significantly improving not only the processability but also the mechanical feature. | 2014-02-20 |
20140051816 | MULTI-COMPONENT CATALYST SYSTEMS FOR THE PRODUCTION OF REACTOR BLENDS OF POLYPROPYLENE - Embodiments of the invention generally include multicomponent catalyst systems, polymerization processes and reactor blends formed by the processes. The multicomponent catalyst system generally includes a first catalyst component selected from an isotactic directing metallocene catalyst. The multicomponent catalyst system further includes a second syndiotactic directing metallocene catalyst component. | 2014-02-20 |
20140051817 | HIGH METATHESIS ACTIVITY RUTHENIUM AND OSMIUM METAL CARBENE COMPLEXES - Ruthenium and osmium carbene compounds that are stable in the presence of a variety of functional groups and can be used to catalyze olefin metathesis reactions on unstrained cyclic and acyclic olefins are disclosed-of the formula | 2014-02-20 |
20140051818 | SYNTHESIS OF HIGH MOLECULAR WEIGHT POLY(2,3,3,3-TETRAFLUOROPROPENE) - A process of synthesizing poly(2,3,3,3-tetrafluoropropene), comprising reacting 2,3,3,3-tetrafluoropropene monomers in a reaction medium in the presence of an initiator, wherein the initiator is added to the reaction medium in multiple portions at different times during the process. | 2014-02-20 |
20140051819 | POLYMERS OF ISOBUTENE FROM RENEWABLE SOURCES - The present invention is directed to a method for preparing isobutene from a renewable source and their use in the preparation of renewable polymers. The invention also discloses purification of isobutene, selective removal of 1-butene, cis-2-butene and trans-2-butene using microporous adsorbent material, and the oligomerization of the purified liquid isobutene yielding diisobutenes and triisobutenes. | 2014-02-20 |
20140051820 | Quasicrystalline Structures and Uses Thereof - This invention relates generally to the field of quasicrystalline structures. In preferred embodiments, the stopgap structure is more spherically symmetric than periodic structures facilitating the formation of stopgaps in nearly all directions because of higher rotational symmetries. More particularly, the invention relates to the use of quasicrystalline structures for optical, mechanical, electrical and magnetic purposes. In some embodiments, the invention relates to manipulating, controlling, modulating and directing waves including electromagnetic, sound, spin, and surface waves, for pre-selected range of wavelengths propagating in multiple directions. | 2014-02-20 |
20140051821 | POLYMERIZABLE COMPOSITIONS, CURED PRODUCTS OBTAINED THEREWITH, AND USE OF THESE MATERIALS - [Problem] To provide a polymerizable composition having an excellent transparency in near-infrared wavelength and excellent heat resistance, and a method for producing the same. | 2014-02-20 |